AES MED LIMITED

Company number 12927227 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

AES MED LIMITED - Analysis Report

Company Number: 12927227

Analysis Date: 2025-07-29 12:51 UTC

  1. Risk Rating: HIGH
    Justification: The company’s latest financials show negative net current assets and net liabilities of £9,242 as of 31 October 2024, a significant deterioration from prior years. This indicates potential solvency issues and inability to cover short-term obligations from current assets.

  2. Key Concerns:

  • Solvency and Liquidity: Negative net current assets and net liabilities suggest the company may struggle to meet immediate creditor demands or operational expenses without additional financing.
  • Rapid Financial Deterioration: The company moved from positive net assets (£299 in 2023) to negative net assets (-£9,242 in 2024) within one year, raising concerns about the sustainability of its business model or financial management.
  • Limited Financial Disclosure: As a micro-entity, financial reporting is minimal, restricting insight into profit/loss, cash flows, or contingencies that could further clarify financial health.
  1. Positive Indicators:
  • Compliance and Filing: The company is current with both accounts and confirmation statement filings, reflecting good regulatory compliance and governance practices.
  • Stable Employment: Maintained an average of two employees over the past two years, indicating some operational continuity despite financial strain.
  • No Indication of Insolvency Proceedings: Company status is active with no liquidation or administration filings, suggesting ongoing business operations.
  1. Due Diligence Notes:
  • Investigate the reasons behind the sharp decline in net assets between 2023 and 2024, including any extraordinary expenses, losses, or write-downs.
  • Review cash flow statements and profitability metrics (not available in micro-entity filings) to assess operational cash generation and sustainability.
  • Confirm whether there are any contingent liabilities, related party transactions, or off-balance sheet commitments that could exacerbate financial stress.
  • Verify the background and financial standing of the sole director, including any previous directorships or involvement in financially distressed entities.

Perspective: Investment Risk Assessor · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.